CHORD ENERGY CORP (CHRD)

US6742152076 - Common Stock

110.83  +0.42 (+0.38%)

After market: 110.4 -0.43 (-0.39%)

Fundamental Rating

5

Overall CHRD gets a fundamental rating of 5 out of 10. We evaluated CHRD against 205 industry peers in the Oil, Gas & Consumable Fuels industry. CHRD has only an average score on both its financial health and profitability. CHRD is not valued too expensively and it also shows a decent growth rate.



5

1. Profitability

1.1 Basic Checks

CHRD had positive earnings in the past year.
In the past year CHRD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHRD reported negative net income in multiple years.
Each year in the past 5 years CHRD had a positive operating cash flow.

1.2 Ratios

CHRD has a better Return On Assets (7.18%) than 62.75% of its industry peers.
CHRD has a Return On Equity (10.66%) which is in line with its industry peers.
CHRD has a Return On Invested Capital (7.87%) which is in line with its industry peers.
CHRD had an Average Return On Invested Capital over the past 3 years of 21.58%. This is significantly below the industry average of 29.03%.
The 3 year average ROIC (21.58%) for CHRD is well above the current ROIC(7.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.18%
ROE 10.66%
ROIC 7.87%
ROA(3y)17.76%
ROA(5y)-23.87%
ROE(3y)30.24%
ROE(5y)-63.14%
ROIC(3y)21.58%
ROIC(5y)13.98%

1.3 Margins

With a decent Profit Margin value of 19.66%, CHRD is doing good in the industry, outperforming 66.18% of the companies in the same industry.
CHRD has a Operating Margin of 24.59%. This is comparable to the rest of the industry: CHRD outperforms 52.94% of its industry peers.
CHRD's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 53.34%, CHRD perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
CHRD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.59%
PM (TTM) 19.66%
GM 53.34%
OM growth 3Y65.82%
OM growth 5Y9.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.37%
GM growth 5Y-0.69%

5

2. Health

2.1 Basic Checks

CHRD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CHRD has been reduced compared to 1 year ago.
CHRD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CHRD has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 1.84 indicates that CHRD is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.84, CHRD perfoms like the industry average, outperforming 56.37% of the companies in the same industry.
The Debt to FCF ratio of CHRD is 3.09, which is a good value as it means it would take CHRD, 3.09 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.09, CHRD is doing good in the industry, outperforming 69.61% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that CHRD is not too dependend on debt financing.
The Debt to Equity ratio of CHRD (0.10) is better than 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.09
Altman-Z 1.84
ROIC/WACC0.88
WACC8.93%

2.3 Liquidity

A Current Ratio of 0.93 indicates that CHRD may have some problems paying its short term obligations.
With a Current ratio value of 0.93, CHRD is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CHRD has a Quick Ratio of 0.93. This is a bad value and indicates that CHRD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.89, CHRD is doing worse than 61.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.89

4

3. Growth

3.1 Past

CHRD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.26%.
Looking at the last year, CHRD shows a very strong growth in Revenue. The Revenue has grown by 20.61%.
Measured over the past years, CHRD shows a quite strong growth in Revenue. The Revenue has been growing by 10.91% on average per year.
EPS 1Y (TTM)-8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.54%
Revenue 1Y (TTM)20.61%
Revenue growth 3Y53.22%
Revenue growth 5Y10.91%
Sales Q2Q%29.12%

3.2 Future

The Earnings Per Share is expected to decrease by -5.71% on average over the next years.
CHRD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.37% yearly.
EPS Next Y-18.34%
EPS Next 2Y-16.48%
EPS Next 3Y-7.71%
EPS Next 5Y-5.71%
Revenue Next Year36.59%
Revenue Next 2Y16.35%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.01, which indicates a rather cheap valuation of CHRD.
82.35% of the companies in the same industry are more expensive than CHRD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CHRD is valued rather cheaply.
CHRD is valuated cheaply with a Price/Forward Earnings ratio of 7.92.
Based on the Price/Forward Earnings ratio, CHRD is valued a bit cheaper than the industry average as 69.61% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.73. CHRD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.01
Fwd PE 7.92

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHRD indicates a somewhat cheap valuation: CHRD is cheaper than 75.00% of the companies listed in the same industry.
CHRD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.11
EV/EBITDA 3.62

4.3 Compensation for Growth

A cheap valuation may be justified as CHRD's earnings are expected to decrease with -7.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.48%
EPS Next 3Y-7.71%

5

5. Dividend

5.1 Amount

CHRD has a Yearly Dividend Yield of 4.53%, which is a nice return.
Compared to an average industry Dividend Yield of 7.14, CHRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, CHRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.53%

5.2 History

CHRD has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CHRD pays out 58.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.05%
EPS Next 2Y-16.48%
EPS Next 3Y-7.71%

CHORD ENERGY CORP

NASDAQ:CHRD (12/20/2024, 8:02:20 PM)

After market: 110.4 -0.43 (-0.39%)

110.83

+0.42 (+0.38%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners94.79%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner Change-0.13%
Market Cap6.78B
Analysts81.9
Price Target183.16 (65.26%)
Short Float %2.49%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield 4.53%
Dividend Growth(5Y)N/A
DP58.05%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-27 2024-11-27 (0.19)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.56%
Min EPS beat(2)-11.89%
Max EPS beat(2)-7.22%
EPS beat(4)2
Avg EPS beat(4)-3.16%
Min EPS beat(4)-11.89%
Max EPS beat(4)3.48%
EPS beat(8)3
Avg EPS beat(8)0.67%
EPS beat(12)5
Avg EPS beat(12)0%
EPS beat(16)8
Avg EPS beat(16)5.89%
Revenue beat(2)2
Avg Revenue beat(2)16.41%
Min Revenue beat(2)9.22%
Max Revenue beat(2)23.6%
Revenue beat(4)4
Avg Revenue beat(4)19.54%
Min Revenue beat(4)8.87%
Max Revenue beat(4)36.47%
Revenue beat(8)8
Avg Revenue beat(8)22.35%
Revenue beat(12)12
Avg Revenue beat(12)35.63%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.37%
PT rev (3m)-12.12%
EPS NQ rev (1m)-3.56%
EPS NQ rev (3m)-45.35%
EPS NY rev (1m)-2.38%
EPS NY rev (3m)-18.79%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-7.7%
Revenue NY rev (1m)1.62%
Revenue NY rev (3m)5.59%
Valuation
Industry RankSector Rank
PE 6.01
Fwd PE 7.92
P/S 1.42
P/FCF 24.11
P/OCF 3.27
P/B 0.77
P/tB 0.82
EV/EBITDA 3.62
EPS(TTM)18.44
EY16.64%
EPS(NY)14
Fwd EY12.63%
FCF(TTM)4.6
FCFY4.15%
OCF(TTM)33.93
OCFY30.61%
SpS77.88
BVpS143.58
TBVpS134.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.18%
ROE 10.66%
ROCE 10.3%
ROIC 7.87%
ROICexc 7.91%
ROICexgc 8.3%
OM 24.59%
PM (TTM) 19.66%
GM 53.34%
FCFM 5.9%
ROA(3y)17.76%
ROA(5y)-23.87%
ROE(3y)30.24%
ROE(5y)-63.14%
ROIC(3y)21.58%
ROIC(5y)13.98%
ROICexc(3y)23.75%
ROICexc(5y)15.29%
ROICexgc(3y)23.75%
ROICexgc(5y)15.33%
ROCE(3y)28.22%
ROCE(5y)18.28%
ROICexcg growth 3Y71.97%
ROICexcg growth 5Y28.13%
ROICexc growth 3Y75.76%
ROICexc growth 5Y28.13%
OM growth 3Y65.82%
OM growth 5Y9.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.37%
GM growth 5Y-0.69%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.09
Debt/EBITDA 0.41
Cap/Depr 193.96%
Cap/Sales 37.66%
Interest Coverage 250
Cash Conversion 98.98%
Profit Quality 30.02%
Current Ratio 0.93
Quick Ratio 0.89
Altman-Z 1.84
F-Score4
WACC8.93%
ROIC/WACC0.88
Cap/Depr(3y)287.55%
Cap/Depr(5y)217.4%
Cap/Sales(3y)32.64%
Cap/Sales(5y)34.49%
Profit Quality(3y)54.66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.54%
EPS Next Y-18.34%
EPS Next 2Y-16.48%
EPS Next 3Y-7.71%
EPS Next 5Y-5.71%
Revenue 1Y (TTM)20.61%
Revenue growth 3Y53.22%
Revenue growth 5Y10.91%
Sales Q2Q%29.12%
Revenue Next Year36.59%
Revenue Next 2Y16.35%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y-13.11%
EBIT growth 3Y154.07%
EBIT growth 5Y21.87%
EBIT Next Year87.49%
EBIT Next 3Y29.18%
EBIT Next 5Y21.5%
FCF growth 1Y-62.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.94%
OCF growth 3Y82.74%
OCF growth 5Y12.8%